Literature DB >> 26301972

Therapeutic potential of curcumin and curcumin analogues in rheumatology.

Biji T Kurien1,2,3, Debashish Danda4, Robert H Scofield5,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26301972      PMCID： PMC7301892          DOI： 10.1111/1756-185X.12753

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  18 in total

1.  Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis.

Authors:  Cheol Park; Dong-Oh Moon; Il-Whan Choi; Byung Tae Choi; Taek-Jeong Nam; Chung-Ho Rhu; Taeg Kyu Kwon; Won Ho Lee; Gi-Young Kim; Yung Hyun Choi
Journal:  Int J Mol Med       Date:  2007-09       Impact factor: 4.101

2.  The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis.

Authors:  J K Jackson; T Higo; W L Hunter; H M Burt
Journal:  Inflamm Res       Date:  2006-04       Impact factor: 4.575

3.  Heat-solubilized curry spice curcumin inhibits antibody-antigen interaction in in vitro studies: a possible therapy to alleviate autoimmune disorders.

Authors:  Biji T Kurien; Anil D'Souza; R Hal Scofield
Journal:  Mol Nutr Food Res       Date:  2010-08       Impact factor: 5.914

4.  Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients.

Authors:  Gianni Belcaro; Maria Rosaria Cesarone; Mark Dugall; Luciano Pellegrini; Andrea Ledda; Maria Giovanna Grossi; Stefano Togni; Giovanni Appendino
Journal:  Altern Med Rev       Date:  2010-12

Review 5.  Multitargeting by curcumin as revealed by molecular interaction studies.

Authors:  Subash C Gupta; Sahdeo Prasad; Ji Hye Kim; Sridevi Patchva; Lauren J Webb; Indira K Priyadarsini; Bharat B Aggarwal
Journal:  Nat Prod Rep       Date:  2011-10-06       Impact factor: 13.423

6.  Improving the solubility and pharmacological efficacy of curcumin by heat treatment.

Authors:  Biji T Kurien; Anil Singh; Hiroyuki Matsumoto; R Hal Scofield
Journal:  Assay Drug Dev Technol       Date:  2007-08       Impact factor: 1.738

7.  Phase II trial of curcumin in patients with advanced pancreatic cancer.

Authors:  Navneet Dhillon; Bharat B Aggarwal; Robert A Newman; Robert A Wolff; Ajaikumar B Kunnumakkara; James L Abbruzzese; Chaan S Ng; Vladimir Badmaev; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

8.  Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1.

Authors:  Jun Li; Yun Wang; Chaozhe Yang; Pengfei Wang; Denise K Oelschlager; Yong Zheng; De-An Tian; William E Grizzle; Donald J Buchsbaum; Mei Wan
Journal:  Mol Pharmacol       Date:  2009-04-24       Impact factor: 4.436

Review 9.  Curcumin: the Indian solid gold.

Authors:  Bharat B Aggarwal; Chitra Sundaram; Nikita Malani; Haruyo Ichikawa
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

10.  Chemopreventive effects of a curcumin-like diarylpentanoid [2,6-bis(2,5-dimethoxybenzylidene)cyclohexanone] in cellular targets of rheumatoid arthritis in vitro.

Authors:  Ka-Heng Lee; Faridah Abas; Noorjahan Banu Mohamed Alitheen; Khozirah Shaari; Nordin Haji Lajis; Daud Ahmad Israf; Ahmad Syahida
Journal:  Int J Rheum Dis       Date:  2014-05-16       Impact factor: 2.454
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.